Point72 Hong Kong’s Health Catalyst HCAT Stock Holding History

Point72 Hong Kong’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,264	Closed	-$33K	–	2123
2022 Q1	$33K	Buy	+1,264	New	+$35.9K	﹤0.01%	1435
2021 Q4	–	Sell	-257	Closed	-$13K	–	2085
2021 Q3	$13K	Buy	257 +97	+61%	+$5.29K	﹤0.01%	1763
2021 Q2	$9K	Buy	+160	New	+$8.52K	﹤0.01%	1749
2020 Q3	–	Sell	-1,199	Closed	-$35K	–	1325
2020 Q2	$35K	Sell	1,199 -582	-33%	-$16.1K	﹤0.01%	795
2020 Q1	$47K	Buy	+1,781	New	+$54.4K	0.02%	363

Other funds holding HCAT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Point72 Hong Kong's HCAT Position: Q2 2022 in Review

Point72 Hong Kong sold out of Health Catalyst (HCAT) in Q2 2022, closing a stake of 1,264 shares — an estimated $33K sold.

Point72 Hong Kong first reported a position in HCAT in Q1 2020 and held it in 5 quarters. The position peaked at $47K in Q1 2020. 180 funds tracked by Wall St. Rank hold HCAT as of Q2 2022.

Point72 Hong Kong reported no remaining Health Catalyst position as of Q2 2022 after selling out during the quarter.
Point72 Hong Kong sold 1,264 Health Catalyst shares in Q2 2022, an estimated $33K.
Point72 Hong Kong first reported a position in Health Catalyst in Q1 2020 and held it in 5 quarters.
Point72 Hong Kong's Health Catalyst position peaked at $47K in Q1 2020.
180 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2022.

Based on Point72 Hong Kong's 13F filing for Q2 2022, filed 15 Aug 2022.